Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Pollack

Showing results (161-170 of 265) with videos related to

Pageof 27
Sort By:
Frontiers in Oncology|November 28, 2017
Automatic Detection and Quantitative DCE-MRI Scoring of Prostate Cancer AggressivenessNestor Andres Parra, Alan Pollack, Felix M Chinea, et al.
Translational Cancer Research|December 1, 2017
Prostate cancer radiomics and the promise of radiogenomicsRadka Stoyanova, Mandeep Takhar, Yohann Tschudi, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 30, 2020
Segmentation of prostate and prostate zones using deep learning : A multi-MRI vendor analysisOlmo Zavala-Romero, Adrian L Breto, Isaac R Xu, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|January 14, 2021
Assessment of daily dose accumulation for robustly optimized intensity modulated proton therapy treatment of prostate cancerYihang Xu, Tejan Diwanji, Nellie Brovold, et al.
Plos One|August 10, 2018
Optimizing patient's selection for prostate biopsy: A single institution experience with multi-parametric MRI and the 4Kscore test for the detection of aggressive prostate cancerSanoj Punnen, Bruno Nahar, Nachiketh Soodana-Prakash, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2014
A tissue biomarker-based model that identifies patients with a high risk of distant metastasis and differential survival by length of androgen deprivation therapy in RTOG protocol 92-02Alan Pollack, James J Dignam, Dayssy A Diaz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2007
Prognostic value of p16 in locally advanced prostate cancer: a study based on Radiation Therapy Oncology Group Protocol 9202Arnab Chakravarti, Michelle DeSilvio, Min Zhang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 13, 2015
Post-radiotherapy prostate biopsies reveal heightened apex positivity relative to other prostate regions sampledKris T Huang, Radka Stoyanova, Gail Walker, et al.
International Journal of Radiation Oncology, Biology, Physics|July 28, 2004
The radiation doses to erectile tissues defined with magnetic resonance imaging after intensity-modulated radiation therapy or iodine-125 brachytherapyMark K Buyyounouski, Eric M Horwitz, Robert G Uzzo, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 12, 2022
SMPDL3b modulates radiation-induced DNA damage response in renal podocytesMarina Francis, Anis Ahmad, Larry Bodgi, et al.
Pageof 27

Showing results (161-170 of 265) with videos related to

Sort By:
Pageof 27
Frontiers in Oncology|November 28, 2017
Automatic Detection and Quantitative DCE-MRI Scoring of Prostate Cancer AggressivenessNestor Andres Parra, Alan Pollack, Felix M Chinea, et al.
Translational Cancer Research|December 1, 2017
Prostate cancer radiomics and the promise of radiogenomicsRadka Stoyanova, Mandeep Takhar, Yohann Tschudi, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 30, 2020
Segmentation of prostate and prostate zones using deep learning : A multi-MRI vendor analysisOlmo Zavala-Romero, Adrian L Breto, Isaac R Xu, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|January 14, 2021
Assessment of daily dose accumulation for robustly optimized intensity modulated proton therapy treatment of prostate cancerYihang Xu, Tejan Diwanji, Nellie Brovold, et al.
Plos One|August 10, 2018
Optimizing patient's selection for prostate biopsy: A single institution experience with multi-parametric MRI and the 4Kscore test for the detection of aggressive prostate cancerSanoj Punnen, Bruno Nahar, Nachiketh Soodana-Prakash, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2014
A tissue biomarker-based model that identifies patients with a high risk of distant metastasis and differential survival by length of androgen deprivation therapy in RTOG protocol 92-02Alan Pollack, James J Dignam, Dayssy A Diaz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2007
Prognostic value of p16 in locally advanced prostate cancer: a study based on Radiation Therapy Oncology Group Protocol 9202Arnab Chakravarti, Michelle DeSilvio, Min Zhang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 13, 2015
Post-radiotherapy prostate biopsies reveal heightened apex positivity relative to other prostate regions sampledKris T Huang, Radka Stoyanova, Gail Walker, et al.
International Journal of Radiation Oncology, Biology, Physics|July 28, 2004
The radiation doses to erectile tissues defined with magnetic resonance imaging after intensity-modulated radiation therapy or iodine-125 brachytherapyMark K Buyyounouski, Eric M Horwitz, Robert G Uzzo, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 12, 2022
SMPDL3b modulates radiation-induced DNA damage response in renal podocytesMarina Francis, Anis Ahmad, Larry Bodgi, et al.
Pageof 27